HIF1A and Parkinson disease: HIF-1α stabilization via HPH inhibition could thus be a potentialstrategy to upregulate therapeutically interesting genes relevant for neuroprotection, vascularization, and dopamine synthesis and it could have therapeutic potential in, for example, Parkinson's disease [29].